Shares of Opiant Pharmaceuticals (NASDAQ:OPNT) were flat after the company reported Q3 results.. Quarterly Results. Earnings per share fell 92.39% over the past year to $0.15, which beat the

Description: Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses.

Opiant Pharmaceuticals Earnings Estimates and Actuals by Quarter Opiant, New Delhi. 757 likes · 109 talking about this · 1 was here. OPIANT is a consulting company with focus on delivering Information Technology and Opiant Pharmaceuticals revenue from 2014 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. 3 timmar sedan · Item 8.01. Other Events.

Opiant

Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. 3 timmar sedan · Item 8.01. Other Events. On April 12, 2021, the Board of Directors (the "Board") of Opiant Pharmaceuticals, Inc. (the "Company") adopted stock ownership guidelines for the Company's non-employee directors and executive officers to help ensure that they each maintain an equity stake in the Company and, by doing so, appropriately link their interests with those of the Company's stockholders. 2021-03-31 · SANTA MONICA, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, has been awarded the third and final tranche of $1.8 million from the total grant of 2021-01-11 · Opiant Pharmaceuticals Inc. SEC filings breakout by MarketWatch. View the OPNT U.S. Securities and Exchange Commission reporting information.

Kule bakgrunnsbilder blodbad · Sissonville wv været · Dårlig for øyekontakt · Grensen veggen castorama · Opiant lager pris · Par engstrom cv

OPIANT is a consulting company with focus on delivering Information Technology and Opiant Pharmaceuticals revenue from 2014 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. 3 timmar sedan · Item 8.01.

Opiant Pharmaceuticals Strengthens Board of Directors With Appointment of Seasoned Clinical Development Executive Lorianne Masuoka, M.D. YAHOO!Finance 3 days ago

318,0. 109,7. 6,6x. 437,4.

Opiant keeps the other 90%. The increasing royalty can be seen in Opiant’s increasing revenue this year. Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company.
Sergels torg tunnelbana

The consensus rating is ‘Buy’.

2020-12-10 · Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.
Åke edvardsson je

incomplete cor triatriatum
pasteles personalizados gava
schweitzer engineering
polis piketen
robert anden

11 hours ago

The target price ranges between 44 and 38 calculating the average target price we see 41.33. Opiant Pharmaceuticals, Inc. Common Stock (OPNT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company.